Acrivon Therapeutics, Inc. (ACRV)

Every official Acrivon Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Acrivon Therapeutics, Inc. documents

• Acrivon Therapeutics, Inc. 10-K 2026ACRV 10-K 2026: annual report for fiscal 2026
• Acrivon Therapeutics, Inc. 10-K 2025ACRV 10-K 2025: annual report for fiscal 2025
• Acrivon Therapeutics, Inc. 10-K 2024ACRV 10-K 2024: annual report for fiscal 2024
• Acrivon Therapeutics, Inc. 10-K 2023ACRV 10-K 2023: annual report for fiscal 2023
• Acrivon Therapeutics, Inc. 10-K 2022ACRV 10-K 2022: annual report for fiscal 2022
• Acrivon Therapeutics, Inc. 10-Q 2026ACRV 10-Q 2026: quarterly report for fiscal 2026
• Acrivon Therapeutics, Inc. 10-Q 2025ACRV 10-Q 2025: quarterly report for fiscal 2025
• Acrivon Therapeutics, Inc. 10-Q 2024ACRV 10-Q 2024: quarterly report for fiscal 2024
• Acrivon Therapeutics, Inc. 10-Q 2023ACRV 10-Q 2023: quarterly report for fiscal 2023
• Acrivon Therapeutics, Inc. 10-Q 2022ACRV 10-Q 2022: quarterly report for fiscal 2022
• Acrivon Therapeutics, Inc. 8-K 2026ACRV 8-K 2026: current report for fiscal 2026
• Acrivon Therapeutics, Inc. 8-K 2025ACRV 8-K 2025: current report for fiscal 2025
• Acrivon Therapeutics, Inc. 8-K 2024ACRV 8-K 2024: current report for fiscal 2024
• Acrivon Therapeutics, Inc. 8-K 2023ACRV 8-K 2023: current report for fiscal 2023
• Acrivon Therapeutics, Inc. 8-K 2022ACRV 8-K 2022: current report for fiscal 2022
• Acrivon Therapeutics, Inc. DEF 14A 2026ACRV DEF 14A 2026: proxy statement for fiscal 2026
• Acrivon Therapeutics, Inc. DEF 14A 2025ACRV DEF 14A 2025: proxy statement for fiscal 2025
• Acrivon Therapeutics, Inc. DEF 14A 2024ACRV DEF 14A 2024: proxy statement for fiscal 2024
• Acrivon Therapeutics, Inc. DEF 14A 2023ACRV DEF 14A 2023: proxy statement for fiscal 2023
• Acrivon Therapeutics, Inc. DEF 14A 2022ACRV DEF 14A 2022: proxy statement for fiscal 2022
• Acrivon Therapeutics, Inc. Form 4 2026ACRV Form 4 2026: insider trading filing for fiscal 2026
• Acrivon Therapeutics, Inc. Form 4 2025ACRV Form 4 2025: insider trading filing for fiscal 2025
• Acrivon Therapeutics, Inc. Form 4 2024ACRV Form 4 2024: insider trading filing for fiscal 2024
• Acrivon Therapeutics, Inc. Form 4 2023ACRV Form 4 2023: insider trading filing for fiscal 2023
• Acrivon Therapeutics, Inc. Form 4 2022ACRV Form 4 2022: insider trading filing for fiscal 2022
• Acrivon Therapeutics, Inc. S-1 2026ACRV S-1 2026: registration statement for fiscal 2026
• Acrivon Therapeutics, Inc. S-1 2025ACRV S-1 2025: registration statement for fiscal 2025
• Acrivon Therapeutics, Inc. S-1 2024ACRV S-1 2024: registration statement for fiscal 2024
• Acrivon Therapeutics, Inc. S-1 2023ACRV S-1 2023: registration statement for fiscal 2023
• Acrivon Therapeutics, Inc. S-1 2022ACRV S-1 2022: registration statement for fiscal 2022
• Acrivon Therapeutics, Inc. 13F 2026ACRV 13F 2026: institutional holdings for fiscal 2026
• Acrivon Therapeutics, Inc. 13F 2025ACRV 13F 2025: institutional holdings for fiscal 2025
• Acrivon Therapeutics, Inc. 13F 2024ACRV 13F 2024: institutional holdings for fiscal 2024
• Acrivon Therapeutics, Inc. 13F 2023ACRV 13F 2023: institutional holdings for fiscal 2023
• Acrivon Therapeutics, Inc. 13F 2022ACRV 13F 2022: institutional holdings for fiscal 2022

More companies